Skip to content
Home
Our Science
Therapeutic Areas
Team & Investors
Careers
News & Resources
Connect
News &
Resources
Featured Stories
MilliporeSigma
MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant
Read More
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
Read More
Siren Biotechnology Awarded $4M in Grant Funding from the California Institute for Regenerative Medicine (CIRM)
Read More
All-In Podcast
2023 All-In Summit – A discussion on the future of gene therapy
Read More
Press Releases
News
Patient Resources
Posted on 3.2.23
Nicole Paulk is named one of the Bay Area’s next generation of life science researchers
Read More
Posted on 12.5.22
Insights from Nicole Paulk on the latest gene therapy for hemophilia B
Read More
Posted on 8.25.22
Siren’s Founder & CEO, Nicole Paulk, speaks on pricing and access for gene therapies
Read More
Posted on 10.1.21
Hear from Nicole Paulk on XLMTM gene therapy
Read More
Posted on 8.12.21
Nicole Paulk on gene therapy’s next steps
Read More
Posted on 5.17.21
Beyond AAV 1.0 – Nicole Paulk discusses breaking down barriers for the future of AAV
Read More
1
2
3
